One More thing, see the attached link. Same Diagram, Same Team, and Same Study Practically Viral Metrics $SBFM @SunshineBio1 @BrettRosen325 @WHO #COVID #omicronusoruyorum #covidcure @deborahrachelb https://t.co/sF5BU6ZSHO
@BrettRosen325 @deborahrachelb So DD, huh? Here's huge news but it's over a year old... so that makes me ask, what are we waiting for? https://t.co/TPgmEgGXd5
RT @JWDayTrader: $SBFM - Sunshine Biopharma Up 30% this week. Looking forward to some big announcements on the horizon. https://t.co/TB8ik8…
RT @JWDayTrader: $SBFM - Sunshine Biopharma Up 30% this week. Looking forward to some big announcements on the horizon. https://t.co/TB8ik8…
$SBFM - Sunshine Biopharma Up 30% this week. Looking forward to some big announcements on the horizon. https://t.co/TB8ik8INfu @BioPharmaDive @pharmaguy #covid @UGAResearch @mtlgazette #biopharma
RT @__ice9: Various ebselen derivatives and analogues have greater potency against SARS-CoV-2 PLpro in vitro, but these would need to be tr…
Various ebselen derivatives and analogues have greater potency against SARS-CoV-2 PLpro in vitro, but these would need to be treated as new drug candidates. https://t.co/kCHBUJICXT Naphthalene derivatives and others from SARS-CoV also look interesting.
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease | ACS Infectious Diseases https://t.co/ZHGglegWSc
#UGA #Scientists publication: Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of #SARSCoV2 Papain-Like Protease https://t.co/2ijLx6a6Vd
RT @AfSynchrotron: [ASAP] Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Li…
[ASAP] Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease https://t.co/StdXFIDpXq via @ACSPublications #chemistry #InfectiousDiseases https://t.co/M3uUI5GzxX
RT @UGAPharmacy: Dr. Scott D. Pegan and Dr. David Crich collaborated with other UGA colleagues to publish a paper on novel therapeutic appr…
RT @UGAPharmacy: Dr. Scott D. Pegan and Dr. David Crich collaborated with other UGA colleagues to publish a paper on novel therapeutic appr…
Dr. Scott D. Pegan and Dr. David Crich collaborated with other UGA colleagues to publish a paper on novel therapeutic approaches of the COVID-19 virus in the American Chemical Society's Infectious Disease journal. Read here: https://t.co/6j1hT9wePc. #phar
Congratulations to Dr. Scott Pegan for his latest publication on novel therapeutic approaches for inhibition of proteins critical to COVID-19 function. Check it out here https://t.co/jC2MesJ6bh. https://t.co/vBQQDhwxOF
Congratulations to Dr. Scott Pegan for his latest publication on novel therapeutic approaches for inhibition of proteins critical to COVID-19 function. Check it out here https://t.co/jC2MesJ6bh. https://t.co/DZjeonAnK6
Congratulations to Dr. Scott Pegan for his latest paper publication. Check it out here https://t.co/jC2MesJ6bh. https://t.co/RGsR74yTTb